News | December 27, 2025
Zeon Corporation to acquire Ushio’s microfluidics biz
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
Xeureka will receive an upfront payment from UBE and will be eligible for milestone payments tied to future research progress
The move strengthens GBL’s clinical-stage presence in the United States
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
The inspection concluded with one minor observation in Form 483
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Subscribe To Our Newsletter & Stay Updated
